Most of our members follow our articles on Croblanc, so you are not very surprised that we talk to you today about the Youtube channel Bloomberg Television! The videos that are broadcasted there have been of great interest to the internet for quite some time now. We think you'll find this video interesting, so we decided to make this post today.
Today, November 9, 2023, the Youtube channel Bloomberg Television has published a new content with the title AstraZeneca CFO: Obesity Market Has a Lot of Potential. If you want to watch this video in streaming, you have come to the right place!
Big buzz for the moment for this last video of Bloomberg Television, indeed the number of views that the video counts is currently much higher than normal. That's why we imagine that if it continues in this direction, the video could very quickly find itself in Youtube trend.
What is convenient with the Internet is that when you have a problem with a content, you can easily contact its author to let him know. To talk to a youtuber (that's how we call content creators on the Youtube platform], go directly to his channel, in the "About" section more precisely. If he doesn't answer you, try again on his social networks: Facebook, Instagram or Twitter for example!
We hope you have enjoyed this article, and that the video AstraZeneca CFO: Obesity Market Has a Lot of Potential has met all your expectations. We hope to see you soon on Croblanc, until then you will be able to watch other videos of Bloomberg Television by searching a little on our dedicated platform. If you have already done the trick, go to Youtube, the content is almost infinite!
All good things must come to an end and this article is no exception to the rule! See you later for the next content to discover on Croblanc!
For your information, you can find below the description of the video AstraZeneca CFO: Obesity Market Has a Lot of Potential published by the Youtube channel Bloomberg Television:
AstraZeneca CFO Aradhana Sarin discusses the company's third-quarter results and its plans to develop an obesity pill. The treatment developed by closely held Chinese biotech Eccogene is in early-stage clinical tests for diabetes. She speaks with Alix Steel and Guy Johnson on "Bloomberg Markets."
Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com
Connect with us on...
Twitter: https://twitter.com/business
Facebook: https://www.facebook.com/bloombergbusiness/
Instagram: https://www.instagram.com/quicktake/?hl=en